Modern medicine keeps unraveling new ways to investigate autoimmunity, leading to the production of boundless amounts of genetic, cellular and imaging data. Although the precision with which this information can define the etiology and mechanisms of a particular autoimmune disease is encouraging, much work lies ahead until all the knowledge acquired can be translated into the clinic. In 'Bedside to Bench', Calliope A. Dendrou, John I. Bell and Lars Fugger discuss the promises and limitations of genome-wide and next-generation genetic studies to provide further understanding of mechanisms driving autoimmune disorders and the role of experimental medicine in the new era of integrative clinical practice and personalized medicine. In 'Bench to Bedside', Lawrence Steinman argues the concept of a 'hub and spoke' pattern of T cell activation and organ targeting in multiple sclerosis, inflammatory bowel disease and type 1 diabetes. This paradigm suggests new ways to develop drugs to keep autoreactive T cells in the organ where activation occurs and preclude them from reaching the target organ and cause disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Defining tissue proteomes by systematic literature review
Scientific Reports Open Access 11 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lewis, T. Lancet 243, 649–651 (1944).
Kitley, J. et al. Brain 135, 1834–1849 (2012).
Klareskog, L., Gregersen, P.K. & Huizinga, T.W. Ann. Rheum. Dis. 69, 2062–2066 (2010).
Curtis, C. et al. Nature 486, 346–352 (2012).
Su, F. et al. N. Engl. J. Med. 366, 207–215 (2012).
Dixon-Salazar, T.J. et al. Sci. Transl. Med. 4, 138ra78 (2012).
Tsoi, L.C. et al. Nat. Genet. 44, 1341–1348 (2012).
Griffiths, C.E.M. et al. N. Engl. J. Med. 362, 118–128 (2010).
Leonardi, C. et al. N. Engl. J. Med. 366, 1190–1199 (2012).
Gregory, A.P. et al. Nature 488, 508–511 (2012).
Cortes, A., Robinson, P. & Brown, M.A. Arthritis Rheum. 64, S1053–S1054 (2012).
Braun, J. et al. Lancet 359, 1187–1193 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Dendrou, C., Bell, J. & Fugger, L. Weighing in on autoimmune disease: Big data tip the scale. Nat Med 19, 138–139 (2013). https://doi.org/10.1038/nm.3087
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3087
This article is cited by
-
Defining tissue proteomes by systematic literature review
Scientific Reports (2018)
-
Neuroinflammation — using big data to inform clinical practice
Nature Reviews Neurology (2016)
-
Immune biomarkers: the promises and pitfalls of personalized medicine
Nature Reviews Immunology (2015)
-
E-health: wat wordt/is de toekomst bij de behandeling van diabetes?
Tijdschrift voor Kindergeneeskunde (2015)
-
The emergence of top-down proteomics in clinical research
Genome Medicine (2013)